Technical Due Diligence for Healthcare Technology Acquisitions

68%

Of healthcare tech acquisitions surface material compliance gaps post-close that were not identified in due diligence

Healthcare technology acquisitions carry regulatory exposure that general-purpose technical due diligence frameworks are not designed to surface. HIPAA compliance gaps, missing Business Associate Agreements, undisclosed FDA clearance status, and ONC CEHRT certification debt appear after the transaction closes â€” when remediation is the acquirer's problem. The due diligence framework that catches these issues before close.

Full article content coming soon.

Industry Intelligence

The engineering behind this article is available as a service.

We have done this work — not advised on it, not reviewed documentation about it. If the problem in this article is your problem, the first call is with a senior engineer who has solved it.

Talk to an Engineer See Case Studies →

Related Reading

Technical Due Diligence for Healthcare Technology Acquisitions

The Offshore Engineering Quality Problem: Why Geography Isn't the Issue

Quantifying Technical Debt in Regulated Systems: The Metric That Matters

Vendor Selection for Regulated Industries: The Technical Due Diligence Framework

The engineering behind this article is available as a service.